Introduction
In recent years, southern Africa has experienced a substantial and persistent outbreak of measles, with the greatest impact seen in children. As southern Africa is also the region of the globe with the highest prevalence of 
Clinical case
LB, an eight-year-old girl, was diagnosed with HIV infection in with measles (January 2010) remained undetectable (less than 400 copies/ml) and CD4 was robust (852 cells/mm 3 ;
see Table I ). Both her weight (18 kg) and height (115.6 cm) remained below minus three standard deviation for weight and height for age at the time of measles diagnosis.
In Intravenous penicillin and vancomycin were started.
Appropriate laboratory investigations were ordered, including blood cultures. She was placed on oxygen via face mask, which brought and maintained her oxygen saturation at 100%. She remained febrile and tachypnoeic and required oxygen throughout the first day of admission.
The following day, a chest film was obtained, which showed bilateral homogenous opacities sparing only the apices (see Figure 1 ). On her third day of admission, LB's condition deteriorated. Mechanical ventilation was not available due to limited capacity in the intensive care unit. During the early hours of hospital day three, LB's condition showed further rapid decline and cardiopulmonary resuscitation was initiated, including epinephrine (0.1 mg/kg 1:1 000) as per protocol. LB failed to respond to resuscitation attempts and expired on hospital day three.
After 72 hours, the blood culture that was drawn on admission grew Staphylococcus aureus sensitive to vancomycin, erythromycin and amikacin.
Discussion
This case demonstrates several features of note when considering measles infection in an HIV-infected child in low-resource settings such as Botswana.
Deaths due to measles are usually caused by bacterial or viral complications of measles, which may occur well after clinical measles has resolved. 3 Bacterial pneumonia, the presumed cause of death in our case, is a common complication of measles and can be associated with bacteraemia or severe acute respiratory distress syndrome, leading to a need for mechanical ventilation 8 and high mortality. 4 Indeed, measles-infected patients have been found to have several-fold higher rates of bacteraemia than non-measles infected, comparably ill general paediatric patients. 9 HIV-infected patients may experience pneumonitis and encephalitis more frequently with measles than HIVuninfected patients, with higher rates of complications and mortality. 10 Neurological sequelae of measles, including subacute encephalitis, subacute sclerosing panencephalitis and myelopathy, have also been reported in HIV-infected patients.
5
HIV infection is likely a risk factor for severe illness with measles, as well as for higher morbidity and case-fatality rates (CFRs) than for HIV-uninfected patients. Older paediatric studies in the Democratic Republic of the Congo (DRC) and Zambia showed CFRs of 31% vs. 28% and 28% vs. 8.3% in HIV-infected vs. HIV-uninfected children.
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A more recent Zambian study found HIV to be a risk factor for mortality in children admitted to hospital with measles, showing an overall CFR of 12.2%, with the presence of HIV doubling the odds of death. 3 HIV-infected children are also more likely to have severe disease, require admission to a hospital and have longer hospital stays than HIV-uninfected VL (copies/ml) ---5 500 < 400
Figure 1: LB's chest x-ray, demonstrating bilateral homogenous opacifications S Afr Fam Pract 2012 children. 13 Immunosuppression, when present, also further increases the risk of severe measles and poor clinical outcome in HIV-infected children. 3 Malnutrition also likely plays a role in the risk of severe measles and poor measles outcomes. At the time of ART initiation, our patient was severely malnourished presumably as a complication of HIV infection. While she had experienced some improvement in nutrition status during her several months on ART, she remained severely malnourished at the time of measles infection. Malnutrition is known to increase susceptibility both to measles infection 14 and to severe measles, including higher CFRs, 15, 16 in both HIV-infected and HIV-uninfected patients. 10 Stunting has a known association with measles infection in HIV-infected children, as does wasting.
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Data from several sub-Saharan African settings have shown that CFRs remain high, despite more than 85% of measles patients' seeking medical care. 17 This underscores the importance of health care workers' maintaining a high clinical suspicion for measles-related complications such as severe pneumonia, which can be especially challenging to manage in low-resource settings. Many such settings lack adequate intensive care resources, including mechanical ventilation, to care for seriously ill children with measles complications, making prompt medical management with effective antibiotics particularly crucial. Lack of available mechanical ventilation likely played a role in our patient's ultimate outcome, and improving capacities to care for critically ill children in low-resource areas deserves attention.
How to achieve proper immunisation of HIV-infected children and maintenance of the very high levels of measles herd immunity required to prevent community-level measles transmission in settings of high HIV prevalence is of great interest. Standard vaccination approaches may result in higher rates of both primary and secondary vaccine failure in HIV-infected children. 5, 18, 19 Once infected with measles, HIVinfected children may have a prolonged infectious period and viral shedding, increasing the risk of transmission to other susceptible groups and potentially perpetuating outbreaks. 18, 20, 21 The recent measles outbreak in southern Africa, despite high levels of measles vaccination coverage at country level across the region, suggests both deficiencies in national measles immunisation strategies and the particular contribution of high HIV prevalence mentioned above.
In Botswana, the current policy is for all children to receive a single measles monovalent immunisation at age nine months, with no booster. Yet, data suggest that 15-20% of children given measles vaccine at age nine months fail to seroconvert compared with much lower rates of failed seroconversion in children immunised between 13 and 18 months, as low as 6-8% in one study. 22 In HIV-infected children in the DRC and Thailand, seroconversion after measles immunisation at nine months has been shown to be as low as 57-65%. 20 children. Management includes clinical decisions such as choice of empirical antibiotic for measlesassociated pneumonia; little data currently exist in this regard. Specific studies along these lines are planned for paediatric populations in Botswana. Their data will assist local health care professionals and national authorities alike, both in further refinements to the approach to measles management in HIVinfected children and in the optimisation of public health measures necessary to control this ancient and relentless foe.
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